Faculty

Back to Index
Peter Albert Singer, MD
Professor of Clinical Medicine
Medicine
CHP 204C Health Sciences Campus Los Angeles
+1 323 442 6179

Overview

Dr. Singer's clinical interests include pituitary disorders, thyroid disease, endocrinology, diabetes and metabolism. He currently serves as Chief of Clinical Endocrinology and Director, Thyroid Diagnostic Center.

Dr. Singer earned his medical degree from University of California, San Francisco. He then performed his internship and residency at LAC+USC Medical Center, followed by an Endocrinology Fellowship.

Awards

Castle Connolly Medical Ltd.: List of America's Top Doctors, 2011

Castle Connolly Medical Ltd. : List of America's Top Doctors, 2011

Keck School of Medicine of USC: Faculty Teaching Award, Year II, 2010

USPH Special Postdoctoral: Fellowship Award, 1972-1973

American Association of Clinical Endocrinologists: Outstanding Clinical Endocrinologist, 2004

LAC+USC Medical Center: Upjohn Award for Most Outstanding Resident in Medicine, 1968-1969

University of California, San Francisco Medical School: Ralph J. Taussig Academic Scholarship, 1964-1965

Keck School of Medicine of USC: Master Professor of Medicine, 1996

University of California, San Francisco Medical School: award conferred by, 1964-1965

American Association of Clinical Endocrinologists: award conferred by, 2004

Keck School of Medicine of USC: award conferred by, 2010

Keck School of Medicine of USC: award conferred by, 1996

USPH Special Postdoctoral: award conferred by, 1972-1973

LAC+USC Medical Center: award conferred by, 1968-1969

Castle Connolly Medical Ltd. : award conferred by, 2011

American Association of Clinical Endocrinologists: has faculty rank, 2004

USPH Special Postdoctoral: has faculty rank, 1972-1973

Keck School of Medicine of USC: has faculty rank, 2010

Keck School of Medicine of USC: has faculty rank, 1996

LAC+USC Medical Center: has faculty rank, 1968-1969

Castle Connolly Medical Ltd. : has faculty rank, 2011

University of California, San Francisco Medical School: has faculty rank, 1964-1965

Keck School of Medicine of USC: award or honor for, 2010

USPH Special Postdoctoral: award or honor for, 1972-1973

American Association of Clinical Endocrinologists: award or honor for, 2004

Castle Connolly Medical Ltd. : award or honor for, 2011

LAC+USC Medical Center: award or honor for, 1968-1969

Keck School of Medicine of USC: award or honor for, 1996

Keck School of Medicine of USC: full name, 1996

University of California, San Francisco Medical School: full name, 1964-1965

USPH Special Postdoctoral: full name, 1972-1973

LAC+USC Medical Center: full name, 1968-1969

American Association of Clinical Endocrinologists: full name, 2004

Keck School of Medicine of USC: full name, 2010

American Association of Clinical Endocrinologists: person in primary position, 2004

Keck School of Medicine of USC: person in primary position, 1996

LAC+USC Medical Center: person in primary position, 1968-1969

Keck School of Medicine of USC: person in primary position, 2010

University of California, San Francisco Medical School: person in primary position, 1964-1965

USPH Special Postdoctoral: person in primary position, 1972-1973

Castle Connolly Medical Ltd. : person in primary position, 2011

American Association of Clinical Endocrinologists: email address, 2004

LAC+USC Medical Center: email address, 1968-1969

USPH Special Postdoctoral: email address, 1972-1973

University of California, San Francisco Medical School: email address, 1964-1965

Castle Connolly Medical Ltd. : email address, 2011

Keck School of Medicine of USC: email address, 1996

Keck School of Medicine of USC: email address, 2010

Keck School of Medicine of USC: is primary position, 2010

LAC+USC Medical Center: is primary position, 1968-1969

USPH Special Postdoctoral: is primary position, 1972-1973

University of California, San Francisco Medical School: is primary position, 1964-1965

Castle Connolly Medical Ltd. : is primary position, 2011

Keck School of Medicine of USC: is primary position, 1996

American Association of Clinical Endocrinologists: is primary position, 2004

American Association of Clinical Endocrinologists: last name, 2004

Castle Connolly Medical Ltd. : last name, 2011

USPH Special Postdoctoral: last name, 1972-1973

Keck School of Medicine of USC: last name, 1996

University of California, San Francisco Medical School: last name, 1964-1965

LAC+USC Medical Center: last name, 1968-1969

Keck School of Medicine of USC: last name, 2010

Castle Connolly Medical Ltd. : HR job title, 2011

University of California, San Francisco Medical School: HR job title, 1964-1965

Keck School of Medicine of USC: HR job title, 2010

USPH Special Postdoctoral: HR job title, 1972-1973

LAC+USC Medical Center: HR job title, 1968-1969

American Association of Clinical Endocrinologists: HR job title, 2004

Keck School of Medicine of USC: HR job title, 1996

Castle Connolly Medical Ltd. : full name, 2011

Keck School of Medicine of USC: Organization, 2010

Castle Connolly Medical Ltd. : Organization, 2011

USPH Special Postdoctoral: Organization, 1972-1973

Keck School of Medicine of USC: Organization, 1996

Castle Connolly Medical Ltd. : position in department, 2011

LAC+USC Medical Center: position in department, 1968-1969

Keck School of Medicine of USC: position in department, 2010

USPH Special Postdoctoral: position in department, 1972-1973

American Association of Clinical Endocrinologists: position in department, 2004

University of California, San Francisco Medical School: position in department, 1964-1965

Keck School of Medicine of USC: position in department, 1996

American Association of Clinical Endocrinologists: Organization, 2004

LAC+USC Medical Center: Organization, 1968-1969

University of California, San Francisco Medical School: Organization, 1964-1965

American Association of Clinical Endocrinologists: Faculty Rank, 2004

Castle Connolly Medical Ltd. : Faculty Rank, 2011

University of California, San Francisco Medical School: Faculty Rank, 1964-1965

LAC+USC Medical Center: Faculty Rank, 1968-1969

USPH Special Postdoctoral: Faculty Rank, 1972-1973

Keck School of Medicine of USC: Faculty Rank, 2010

Keck School of Medicine of USC: Faculty Rank, 1996

USPH Special Postdoctoral: sort order, 1972-1973

Keck School of Medicine of USC: sort order, 2010

University of California, San Francisco Medical School: sort order, 1964-1965

Castle Connolly Medical Ltd. : sort order, 2011

Keck School of Medicine of USC: sort order, 1996

LAC+USC Medical Center: sort order, 1968-1969

American Association of Clinical Endocrinologists: sort order, 2004

University of California, San Francisco Medical School: start date, 1964-1965

LAC+USC Medical Center: start date, 1968-1969

American Association of Clinical Endocrinologists: start date, 2004

Castle Connolly Medical Ltd. : start date, 2011

Keck School of Medicine of USC: start date, 2010

Keck School of Medicine of USC: start date, 1996

USPH Special Postdoctoral: start date, 1972-1973

Keck School of Medicine of USC: type, 1996

Keck School of Medicine of USC: type, 2010

LAC+USC Medical Center: type, 1968-1969

Castle Connolly Medical Ltd. : type, 2011

USPH Special Postdoctoral: type, 1972-1973

American Association of Clinical Endocrinologists: type, 2004

University of California, San Francisco Medical School: type, 1964-1965

American Association of Clinical Endocrinologists: Person ID, 2004

Castle Connolly Medical Ltd. : Person ID, 2011

USPH Special Postdoctoral: Person ID, 1972-1973

University of California, San Francisco Medical School: Person ID, 1964-1965

Keck School of Medicine of USC: Person ID, 1996

LAC+USC Medical Center: Person ID, 1968-1969

Keck School of Medicine of USC: Person ID, 2010

LAC+USC Medical Center: end date, 1968-1969

Castle Connolly Medical Ltd. : Professor of Clinical Medicine, 2011

Keck School of Medicine of USC: Professor of Clinical Medicine, 1996

USPH Special Postdoctoral: end date, 1972-1973

University of California, San Francisco Medical School: end date, 1964-1965

American Association of Clinical Endocrinologists: Professor of Clinical Medicine, 2004

Keck School of Medicine of USC: Professor of Clinical Medicine, 2010

USPH Special Postdoctoral: Keck School of Medicine of USC, 1972-1973

University of California, San Francisco Medical School: Keck School of Medicine of USC, 1964-1965

Keck School of Medicine of USC: Keck School of Medicine of USC, 2010

LAC+USC Medical Center: Keck School of Medicine of USC, 1968-1969

American Association of Clinical Endocrinologists: Keck School of Medicine of USC, 2004

Castle Connolly Medical Ltd. : Keck School of Medicine of USC, 2011

Keck School of Medicine of USC: Keck School of Medicine of USC, 1996

University of California, San Francisco Medical School: workplace homepage, 1964-1965

USPH Special Postdoctoral: workplace homepage, 1972-1973

Keck School of Medicine of USC: workplace homepage, 1996

Castle Connolly Medical Ltd. : workplace homepage, 2011

LAC+USC Medical Center: workplace homepage, 1968-1969

American Association of Clinical Endocrinologists: workplace homepage, 2004

Keck School of Medicine of USC: workplace homepage, 2010

Castle Connolly Medical Ltd. : Singer, Peter, 2011

LAC+USC Medical Center: Singer, Peter, 1968-1969

University of California, San Francisco Medical School: Singer, Peter, 1964-1965

Keck School of Medicine of USC: Singer, Peter, 1996

American Association of Clinical Endocrinologists: Singer, Peter, 2004

USPH Special Postdoctoral: Singer, Peter, 1972-1973

Keck School of Medicine of USC: Singer, Peter, 2010

American Association of Clinical Endocrinologists: position in organization, 2004

Keck School of Medicine of USC: position in organization, 2010

Keck School of Medicine of USC: position in organization, 1996

Castle Connolly Medical Ltd. : position in organization, 2011

USPH Special Postdoctoral: position in organization, 1972-1973

LAC+USC Medical Center: position in organization, 1968-1969

University of California, San Francisco Medical School: position in organization, 1964-1965

University of California, San Francisco Medical School: award or honor for, 1964-1965

Keck School of Medicine of USC: Person, 2010

LAC+USC Medical Center: Person, 1968-1969

University of California, San Francisco Medical School: Person, 1964-1965

American Association of Clinical Endocrinologists: Person, 2004

USPH Special Postdoctoral: Person, 1972-1973

Keck School of Medicine of USC: Person, 1996

Castle Connolly Medical Ltd. : Person, 2011

Castle Connolly Medical Ltd. : preferred title, 2011

Keck School of Medicine of USC: preferred title, 1996

LAC+USC Medical Center: preferred title, 1968-1969

Keck School of Medicine of USC: preferred title, 2010

University of California, San Francisco Medical School: preferred title, 1964-1965

LAC+USC Medical Center: first name, 1968-1969

American Association of Clinical Endocrinologists: first name, 2004

University of California, San Francisco Medical School: first name, 1964-1965

USPH Special Postdoctoral: first name, 1972-1973

Keck School of Medicine of USC: first name, 2010

Keck School of Medicine of USC: first name, 1996

Castle Connolly Medical Ltd. : first name, 2011

LAC+USC Medical Center: Agent, 1968-1969

University of California, San Francisco Medical School: Agent, 1964-1965

Castle Connolly Medical Ltd. : Agent, 2011

American Association of Clinical Endocrinologists: Agent, 2004

Keck School of Medicine of USC: Agent, 1996

Keck School of Medicine of USC: Medicine, 1996

LAC+USC Medical Center: Medicine, 1968-1969

University of California, San Francisco Medical School: Medicine, 1964-1965

Keck School of Medicine of USC: Medicine, 2010

USPH Special Postdoctoral: Medicine, 1972-1973

American Association of Clinical Endocrinologists: Medicine, 2004

Keck School of Medicine of USC: Professor, 2010

American Association of Clinical Endocrinologists: Professor, 2004

Castle Connolly Medical Ltd. : Professor, 2011

LAC+USC Medical Center: Professor, 1968-1969

Keck School of Medicine of USC: Professor, 1996

University of California, San Francisco Medical School: Professor, 1964-1965

USPH Special Postdoctoral: Professor, 1972-1973

Keck School of Medicine of USC: Award or Honor Receipt, 2010

LAC+USC Medical Center: Award or Honor Receipt, 1968-1969

American Association of Clinical Endocrinologists: Award or Honor Receipt, 2004

Castle Connolly Medical Ltd. : Award or Honor Receipt, 2011

Keck School of Medicine of USC: Award or Honor Receipt, 1996

USPH Special Postdoctoral: Award or Honor Receipt, 1972-1973

University of California, San Francisco Medical School: Award or Honor Receipt, 1964-1965

Keck School of Medicine of USC: label, 1996

American Association of Clinical Endocrinologists: label, 2004

Castle Connolly Medical Ltd. : label, 2011

Keck School of Medicine of USC: label, 2010

USPH Special Postdoctoral: label, 1972-1973

LAC+USC Medical Center: label, 1968-1969

University of California, San Francisco Medical School: label, 1964-1965

USPH Special Postdoctoral: Agent, 1972-1973

Keck School of Medicine of USC: Agent, 2010

Keck School of Medicine of USC: Position, 2010

University of California, San Francisco Medical School: Position, 1964-1965

LAC+USC Medical Center: Position, 1968-1969

Castle Connolly Medical Ltd. : Position, 2011

American Association of Clinical Endocrinologists: Position, 2004

Keck School of Medicine of USC: Position, 1996

USPH Special Postdoctoral: Position, 1972-1973

Keck School of Medicine of USC: photo, 2010

American Association of Clinical Endocrinologists: photo, 2004

University of California, San Francisco Medical School: photo, 1964-1965

LAC+USC Medical Center: photo, 1968-1969

Castle Connolly Medical Ltd. : photo, 2011

Publications

Replenishment of the Global Fund: global solidarity needed. Lancet. 2016 Sep 17; 388(10050):1139-41. View in: PubMed

Got Rice? An Unusual Case of Iodine-Deficiency Hypothyroidism. Thyroid. 2016 Sep; 26(9):1338-9. View in: PubMed

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent. Thyroid. 2016 Mar; 26(3):381-9. View in: PubMed

Innovating for women's, children's, and adolescents' health. BMJ. 2015; 351:h4151. View in: PubMed

SDGs: start with maternal, newborn, and child health cluster. Lancet. 2014 Sep 20; 384(9948):1093-4. View in: PubMed

A focus on child development. Science. 2014 Jul 11; 345(6193):121. View in: PubMed

In response. Endocr Pract. 2013 Nov-Dec; 19(6):1064-5. View in: PubMed

Discussing infanticide. J Med Ethics. 2013 May; 39(5):260. View in: PubMed

Addressing ethical, social, and cultural issues in global health research. PLoS Negl Trop Dis. 2013; 7(8):e2227. View in: PubMed

Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012 Dec; 22(12):1200-35. View in: PubMed

Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012 Nov-Dec; 18(6):988-1028. View in: PubMed

Innovative drugs and vaccines in China, India and Brazil. Nat Biotechnol. 2012 Oct; 30(10):923-6. View in: PubMed

Factors influencing agbiotech adoption and development in sub-Saharan Africa. Nat Biotechnol. 2012 Jan; 30(1):38-40. View in: PubMed

Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators. Health Res Policy Syst. 2012; 10:18. View in: PubMed

Grand challenges in global mental health. Nature. 2011 Jul 7; 475(7354):27-30. View in: PubMed

How not to save a life. Bioethics. 2011 Jun; 25(5):ii-iii. View in: PubMed

Access to life-saving medicines and intellectual property rights: an ethical assessment. Camb Q Healthc Ethics. 2011 Apr; 20(2):279-89. View in: PubMed

Access and use of human tissues from the developing world: ethical challenges and a way forward using a tissue trust. BMC Med Ethics. 2011; 12:2. View in: PubMed

Franchising rabies vaccine delivery: the case of Indian immunologicals. PLoS Negl Trop Dis. 2011; 5(4):e946. View in: PubMed

The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries. BMC Public Health. 2011; 11:811. View in: PubMed

Indian vaccine innovation: the case of Shantha Biotechnics. Global Health. 2011; 7:9. View in: PubMed

What could infant and young child nutrition learn from sweatshops? BMC Public Health. What could infant and young child nutrition learn from sweatshops? BMC Public Health. 2011; 11:276. View in: PubMed

Global health. Stagnant health technologies in Africa. Science. 2010 Dec 10; 330(6010):1483-4. View in: PubMed

Regenerative medicine in Brazil: small but innovative. Regen Med. 2010 Nov; 5(6):863-76. View in: PubMed

Global health or global wealth? Nat Biotechnol. Global health or global wealth? Nat Biotechnol. 2010 Sep; 28(9):907-9. View in: PubMed

Case study: India's billion dollar biotech. Nat Biotechnol. 2010 Aug; 28(8):783. View in: PubMed

Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid. 2010 Jun; 20(6):587-95. View in: PubMed

South-South entrepreneurial collaboration in health biotech. Nat Biotechnol. 2010 May; 28(5):407-16. View in: PubMed

Is there an ethical obligation to complete polio eradication? Lancet. Is there an ethical obligation to complete polio eradication? Lancet. 2010 Apr 17; 375(9723):1340-1. View in: PubMed

Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas. J Neurosurg. 2010 Apr; 112(4):744-9. View in: PubMed

Responsibilities in international research: a new look revisited. J Med Ethics. 2010 Apr; 36(4):194-7. View in: PubMed

Evaluating priority setting success in healthcare: a pilot study. BMC Health Serv Res. 2010; 10:131. View in: PubMed

Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA). BMC Int Health Hum Rights. 2010; 10 Suppl 1:S9. View in: PubMed

Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S8. View in: PubMed

Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S7. View in: PubMed

Africa's largest long-lasting insecticide-treated net producer: lessons from A to Z Textiles. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S6. View in: PubMed

Science-based health innovation in Uganda: creative strategies for applying research to development. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S5. View in: PubMed

Science-based health innovation in Tanzania: bednets and a base for invention. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S4. View in: PubMed

Science-based health innovation in Rwanda: unlocking the potential of a late bloomer. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S3. View in: PubMed

Science-based health innovation in Ghana: health entrepreneurs point the way to a new development path. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S2. View in: PubMed

Venture funding for science-based African health innovation. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S12. View in: PubMed

The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S11. View in: PubMed

Turning science into health solutions: KEMRI's challenges as Kenya's health product pathfinder. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S10. View in: PubMed

Science-based health innovation in sub-Saharan Africa. BMC Int Health Hum Rights. 2010; 10 Suppl 1:S1. View in: PubMed

Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? Health Res Policy Syst. Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? Health Res Policy Syst. 2010; 8:24. View in: PubMed

Addressing conflicts of interest in Public Private Partnerships. BMC Int Health Hum Rights. 2010; 10:19. View in: PubMed

'Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world. BMC Public Health. 2010; 10:384. View in: PubMed

Cultivating regenerative medicine innovation in China. Regen Med. 2010 Jan; 5(1):35-44. View in: PubMed

Shared principles of ethics for infant and young child nutrition in the developing world. BMC Public Health. 2010; 10:321. View in: PubMed

Guidance for reconciling patent rights and disclosure of findings at scientific meetings. Health Res Policy Syst. 2010; 8:15. View in: PubMed

Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world? BMC Int Health Hum Rights. Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world? BMC Int Health Hum Rights. 2010; 10:8. View in: PubMed

A business plan to help the 'global South' in its fight against neglected diseases. Health Aff (Millwood). 2009 Nov-Dec; 28(6):1760-73. View in: PubMed

Globetrotting firms: Canada's health biotechnology collaborations with developing countries. Nat Biotechnol. 2009 Sep; 27(9):806-14. View in: PubMed

In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs? PLoS Med. In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs? PLoS Med. 2009 Jun 9; 6(6):e1000071. View in: PubMed

Small but tenacious: South Africa's health biotech sector. Nat Biotechnol. 2009 May; 27(5):427-45. View in: PubMed

A survey of South-North health biotech collaboration. Nat Biotechnol. 2009 Mar; 27(3):229-32. View in: PubMed

Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Serv Res. 2009; 9:43. View in: PubMed

Sex, gender, and health biotechnology: points to consider. BMC Int Health Hum Rights. 2009; 9:15. View in: PubMed

The three main monotheistic religions and gm food technology: an overview of perspectives. BMC Int Health Hum Rights. 2009; 9:18. View in: PubMed

From diversity to delivery: the case of the Indian Genome Variation initiative. Nat Rev Genet. 2008 Oct; 9 Suppl 1:S9-14. View in: PubMed

Universal health care, genomic medicine and Thailand: investing in today and tomorrow. Nat Rev Genet. 2008 Oct; 9 Suppl 1:S14-9. View in: PubMed

South Africa: from species cradle to genomic applications. Nat Rev Genet. 2008 Oct; 9 Suppl 1:S19-23. View in: PubMed

The next steps for genomic medicine: challenges and opportunities for the developing world. Nat Rev Genet. 2008 Oct; 9 Suppl 1:S23-7. View in: PubMed

Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nat Rev Genet. 2008 Oct; 9 Suppl 1:S5-9. View in: PubMed

Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada. Health Policy. 2008 Sep; 87(3):359-68. View in: PubMed

Harnessing stem cells for health needs in India. Cell Stem Cell. 2008 Jul 3; 3(1):11-5. View in: PubMed

The Indian and Chinese health biotechnology industries: potential champions of global health? Health Aff (Millwood). The Indian and Chinese health biotechnology industries: potential champions of global health? Health Aff (Millwood). 2008 Jul-Aug; 27(4):1029-41. View in: PubMed

Genomic medicine and developing countries: creating a room of their own. Nat Rev Genet. 2008 Jun; 9(6):487-93. View in: PubMed

Brazilian health biotech--fostering crosstalk between public and private sectors. Nat Biotechnol. 2008 Jun; 26(6):627-44. View in: PubMed

Public engagement on global health challenges. BMC Public Health. 2008; 8:168. View in: PubMed

Chinese health biotech and the billion-patient market. Nat Biotechnol. 2008 Jan; 26(1):37-53. View in: PubMed

Grand challenges in chronic non-communicable diseases. Nature. 2007 Nov 22; 450(7169):494-6. View in: PubMed

Motivating action: why should Canadian physicians participate in research, education, or patient care in the developing world? Can Fam Physician. Motivating action: why should Canadian physicians participate in research, education, or patient care in the developing world? Can Fam Physician. 2007 Nov; 53(11):1849-51, 1863-5. View in: PubMed

A tough transition. Nature. 2007 Sep 13; 449(7159):160-3. View in: PubMed

Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. PLoS Med. 2007 Sep; 4(9):e272. View in: PubMed

Grand challenges in global health: the ethical, social and cultural program. PLoS Med. 2007 Sep; 4(9):e265. View in: PubMed

Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 2007 Sep; 4(9):e273. View in: PubMed

North-South partnerships--a study of Canadian firms. Nat Biotechnol. 2007 Sep; 25(9):978-9. View in: PubMed

Grand challenges in global health: ethical, social, and cultural issues based on key informant perspectives. PLoS Med. 2007 Sep; 4(9):e268. View in: PubMed

India's health biotech sector at a crossroads. Nat Biotechnol. 2007 Apr; 25(4):403-17. View in: PubMed

Priority setting and cardiac surgery: a qualitative case study. Health Policy. 2007 Mar; 80(3):444-58. View in: PubMed

Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. Mol Imaging Biol. 2007 Mar-Apr; 9(2):72-7. View in: PubMed

A visual dashboard for moving health technologies from "lab to village". J Med Internet Res. 2007; 9(4):e32. View in: PubMed

Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg. 2007 Jan; 106(1):66-71. View in: PubMed

How can developing countries harness biotechnology to improve health? BMC Public Health. How can developing countries harness biotechnology to improve health? BMC Public Health. 2007; 7:346. View in: PubMed

Leadership and priority setting: the perspective of hospital CEOs. Health Policy. 2006 Nov; 79(1):24-34. View in: PubMed

Regenerative medicine and the developing world. PLoS Med. 2006 Sep; 3(9):e381. View in: PubMed

2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer. Mol Imaging Biol. 2006 Sep-Oct; 8(5):309-14. View in: PubMed

Science community: scientific diasporas. Science. 2006 Jun 16; 312(5780):1602-3. View in: PubMed

Deeper lessons from the CMAJ debacle. Lancet. 2006 May 13; 367(9522):1551-3. View in: PubMed

Lessons on ethical decision making from the bioscience industry. PLoS Med. 2006 May; 3(5):e129. View in: PubMed

Just regionalisation: rehabilitating care for people with disabilities and chronic illnesses. BMC Med Ethics. 2006; 7:E9. View in: PubMed

Cross border shopping: how much for your heart? Healthc Q. Cross border shopping: how much for your heart? Healthc Q. 2006; 9(4):81-3. View in: PubMed

1980-2005: bioethics then and now. Monash Bioeth Rev. 2006 Jan; 25(1):9-14. View in: PubMed

Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy. Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy. 2006 Jan; 11(1):32-7. View in: PubMed

Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences. Soc Sci Med. 2005 Dec; 61(11):2355-62. View in: PubMed

Making our own decisions about death: competency should be paramount. Free Inq. 2005 Aug-Sep; 25(5):36-8. View in: PubMed

Health innovation networks to help developing countries address neglected diseases. Science. 2005 Jul 15; 309(5733):401-4. View in: PubMed

Global health challenges: the need for an expanded discourse on bioethics. PLoS Med. 2005 Jul; 2(7):e143. View in: PubMed

Hospital priority setting with an appeals process: a qualitative case study and evaluation. Health Policy. 2005 Jul; 73(1):10-20. View in: PubMed

Top 10 health care ethics challenges facing the public: views of Toronto bioethicists. BMC Med Ethics. 2005 Jun 26; 6:E5. View in: PubMed

Nanotechnology and the developing world. PLoS Med. 2005 May; 2(5):e97. View in: PubMed

A randomized trial of teaching bioethics to surgical residents. Am J Surg. 2005 Apr; 189(4):453-7. View in: PubMed

Pharmacogenetics and geographical ancestry: implications for drug development and global health. Nat Rev Genet. 2005 Mar; 6(3):241-6. View in: PubMed

Law reform, or DIY suicide. Free Inq. 2005 Feb-Mar; 25(2):19-20. View in: PubMed

"Harnessing genomics to improve health in Africa" - an executive course to support genomics policy. Health Res Policy Syst. 2005 Jan 24; 3(1):2. View in: PubMed

What do hospital decision-makers in Ontario, Canada, have to say about the fairness of priority setting in their institutions? BMC Health Serv Res. What do hospital decision-makers in Ontario, Canada, have to say about the fairness of priority setting in their institutions? BMC Health Serv Res. 2005 Jan 21; 5(1):8. View in: PubMed

Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy. Health Res Policy Syst. 2005 Jan 21; 3(1):1. View in: PubMed

Evidence, economics and ethics: resource allocation in health services organizations. Healthc Q. 2005; 8(2):50-9, 4. View in: PubMed

Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005 Jan; 90(1):581-5; discussion 586-7. View in: PubMed

Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 2005 Jan; 15(1):24-8; response 32-3. View in: PubMed

Transatlantic divide in publication of content relevant to developing countries. BMJ. 2004 Dec 18; 329(7480):1429-30. View in: PubMed

South Africa--blazing a trail for African biotechnology. Nat Biotechnol. 2004 Dec; 22 Suppl:DC37-41. View in: PubMed

Indian biotechnology--rapidly evolving and industry led. Nat Biotechnol. 2004 Dec; 22 Suppl:DC31-6. View in: PubMed

The emergence of Egyptian biotechnology from generics. Nat Biotechnol. 2004 Dec; 22 Suppl:DC25-30. View in: PubMed

Cuba--innovation through synergy. Nat Biotechnol. 2004 Dec; 22 Suppl:DC19-24. View in: PubMed

Health biotechnology in China--reawakening of a giant. Nat Biotechnol. 2004 Dec; 22 Suppl:DC13-8. View in: PubMed

South Korean biotechnology--a rising industrial and scientific powerhouse. Nat Biotechnol. 2004 Dec; 22 Suppl:DC42-7. View in: PubMed

The scientific muscle of Brazil's health biotechnology. Nat Biotechnol. 2004 Dec; 22 Suppl:DC8-12. View in: PubMed

Conclusions: promoting biotechnology innovation in developing countries. Nat Biotechnol. 2004 Dec; 22 Suppl:DC48-52. View in: PubMed

Strengthening the role of genomics in global health. PLoS Med. 2004 Dec; 1(3):e40. View in: PubMed

Introduction: promoting global health through biotechnology. Nat Biotechnol. 2004 Dec; 22 Suppl:DC3-7. View in: PubMed

Stem cell research: the fallacy in Bush's position. N J Med. 2004 Dec; 101(12):14-7. View in: PubMed

Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocr Pract. 2004 Nov-Dec; 10(6):497-501. View in: PubMed

Setting priorities in health care organizations: criteria, processes, and parameters of success. BMC Health Serv Res. 2004 Sep 8; 4(1):25. View in: PubMed

Consent to the publication of patient information. BMJ. 2004 Sep 4; 329(7465):566-8. View in: PubMed

The pope moves backward on terminal case. Free Inq. 2004 Aug-Sep; 24(5):19-20. View in: PubMed

The harm that religion does. Free Inq. 2004 Jun-Jul; 24(4):17, 58. View in: PubMed

Biotechnology to improve health in developing countries -- a review. Mem Inst Oswaldo Cruz. 2004 Jun; 99(4):341-50. View in: PubMed

Can a "good death" be made better?: A preliminary evaluation of a patient-centred quality improvement strategy for severely ill in-patients. BMC Palliat Care. 2004 May 23; 3(1):2. View in: PubMed

"Harnessing genomics to improve health in India" - an executive course to support genomics policy. Health Res Policy Syst. 2004 May 19; 2(1):1. View in: PubMed

The ELSI genetics regulatory resource kit: a tool for policymakers in developing countries. J Law Med Ethics. 2004; 32(4):692-700. View in: PubMed

Legal and ethical approaches to stem cell and cloning research: a comparative analysis of policies in Latin America, Asia, and Africa. J Law Med Ethics. 2004; 32(4):626-40. View in: PubMed

Ethics and SARS: lessons from Toronto. BMJ. 2003 Dec 6; 327(7427):1342-4. View in: PubMed

Priority setting in a hospital drug formulary: a qualitative case study and evaluation. Health Policy. 2003 Dec; 66(3):295-303. View in: PubMed

Priority setting in a hospital critical care unit: qualitative case study. Crit Care Med. 2003 Dec; 31(12):2764-8. View in: PubMed

Biotechnology and the UN's Millennium Development Goals. Nat Biotechnol. 2003 Dec; 21(12):1434-6. View in: PubMed

Interdisciplinary research: putting the methods under the microscope. BMC Med Res Methodol. 2003 Oct 19; 3:20. View in: PubMed

Voluntary euthanasia: a utilitarian perspective. Bioethics. 2003 Oct; 17(5-6):526-41. View in: PubMed

Priority-setting and hospital strategic planning: a qualitative case study. J Health Serv Res Policy. 2003 Oct; 8(4):197-201. View in: PubMed

Priority setting in surgery: improve the process and share the learning. World J Surg. 2003 Aug; 27(8):962-6. View in: PubMed

"The best places to die". BMJ. 2003 Jul 26; 327(7408):173-4. View in: PubMed

We've come a long way, ATA. Thyroid. 2003 Jul; 13(7):611-2. View in: PubMed

Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg. 2003 May; 98(5):967-73. View in: PubMed

Strengthening the role of ethics in medical education. CMAJ. 2003 Apr 1; 168(7):854-5. View in: PubMed

Genomics--a global public good? Lancet. Genomics--a global public good? Lancet. 2003 Mar 15; 361(9361):891-2. View in: PubMed

Intensive care nurses' and physicians' experiences with demands for treatment: some implications for clinical practice. J Crit Care. 2003 Mar; 18(1):17-21. View in: PubMed

Seasonal bed closures in an intensive care unit: a qualitative study. J Crit Care. 2003 Mar; 18(1):25-30. View in: PubMed

A strategy to improve priority setting in health care institutions. Health Care Anal. 2003 Mar; 11(1):59-68. View in: PubMed

Intimate examinations and other ethical challenges in medical education. BMJ. 2003 Jan 11; 326(7380):62-3. View in: PubMed

CPR for patients labeled DNR: the role of the limited aggressive therapy order. Ann Intern Med. 2003 Jan 7; 138(1):65-8. View in: PubMed

Ontario's formulary committee: how recommendations are made. Pharmacoeconomics. 2003; 21(4):285-94. View in: PubMed

Postoperative endocrine management of pituitary tumors. Neurosurg Clin N Am. 2003 Jan; 14(1):123-38. View in: PubMed

Isolationism is not the answer to bioterrorism. Nature. 2002 Dec 12; 420(6916):605. View in: PubMed

Participation in health care priority-setting through the eyes of the participants. J Health Serv Res Policy. 2002 Oct; 7(4):222-9. View in: PubMed

Top ten biotechnologies for improving health in developing countries. Nat Genet. 2002 Oct; 32(2):229-32. View in: PubMed

Fairness, accountability for reasonableness, and the views of priority setting decision-makers. Health Policy. 2002 Sep; 61(3):279-90. View in: PubMed

Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics. 2002 Aug 12; 3:E3. View in: PubMed

Quality end-of-life care: A global perspective. BMC Palliat Care. 2002 Jul 25; 1(1):4. View in: PubMed

Priority setting for new technologies in medicine: a transdisciplinary study. BMC Health Serv Res. 2002 Jul 18; 2(1):14. View in: PubMed

Quality care at the end of life. BMJ. 2002 Jun 1; 324(7349):1291-2. View in: PubMed

Freedom and the right to die. Free Inq. 2002; 22(2):16-7. View in: PubMed

Clinical ethics revisited. BMC Med Ethics. 2001; 2:E1. View in: PubMed

Still no academic freedom in Germany. Bioethics. 1999 Apr; 13(2):iii-. View in: PubMed

Living and dying. Psychol Today. 1999 Jan-Feb; 32(1):56-59, 78-79. View in: PubMed

On the ethics of bringing people into existence. Bioethics. 1998 Apr; 12(2):iii-. View in: PubMed

Cloning our way to Armageddon? Bioethics. Cloning our way to Armageddon? Bioethics. 1997 Oct; 11(5):iii-. View in: PubMed

From the editors. Bioethics. 1997 Apr; 11(2):iii-. View in: PubMed

From the editors: Bob Dent's decision. Bioethics. 1997 Jan; 11(1):iii-. View in: PubMed

Non-Western bioethics. Bioethics. 1996 Jul; 10(3):iii-. View in: PubMed

Randomization in controlled trials. Bioethics. 1996 Apr; 10(2):iii-. View in: PubMed

A report from Australia: the legalisation of voluntary euthanasia in the Northern Territory. Bioethics. 1995 Oct; 9(5):419-24. View in: PubMed

The Great Ape Project: premises and implications. Altern Lab Anim. 1995 Sep-Oct; 23(5):626-31. View in: PubMed

Is the sanctity of life ethic terminally ill? Bioethics. Is the sanctity of life ethic terminally ill? Bioethics. 1995 Jul; 9(3-4):327-42. View in: PubMed

Direct aid in dying: which state will be next? Bioethics. Direct aid in dying: which state will be next? Bioethics. 1995 Apr; 9(2):iii-. View in: PubMed

The incommensurability of research risks and benefits: practical help for research ethics committees. IRB. 1995 Mar-Apr; 17(2):8-10. View in: PubMed

Questionable experiments, muddled defence. Bioethics. 1994 Oct; 8(4):iii-. View in: PubMed

Whose life? Bioethics. Whose life? Bioethics. 1994 Jul; 8(3):iii-. View in: PubMed

From the editors. Bioethics. 1994 Apr; 8(2):iii-. View in: PubMed

The University of Toronto Centre for Bioethics living will. Humane Med. 1993 Oct; 9(4):263. View in: PubMed

From the editors. Bioethics. 1993 Jul; 7(4):iii-. View in: PubMed

More on euthanasia: a response to Pauer-Studer. Monist. 1993 Apr; 76(2):158-74. View in: PubMed

From the editors. Bioethics. 1993 Apr; 7(2-3):v-. View in: PubMed

University of Toronto Centre for Bioethics living will. Ont Med Rev. 1993 Jan; 35, 37, 39-41. View in: PubMed

From the editors. Bioethics. 1993 Jan; 7(1):iii-. View in: PubMed

From the editors. Bioethics. 1992 Oct; 6(4):iii-. View in: PubMed

The University of Toronto Centre for Bioethics. Humane Med. 1992 Jul; 8(3):219-24. View in: PubMed

Bioethics at Monash University. J Int Bioethique. 1992 Jun; 3(2):111-5. View in: PubMed

From the editors. Bioethics. 1992 Jan; 6(1):iii-. View in: PubMed

The case of Nancy Cruzan, the Patient Self-Determination Act and advance directives in Canada. Humane Med. 1991 Aug; 7(3):225-7. View in: PubMed

From the editors. Bioethics. 1991 Apr; 5(2):iii-. View in: PubMed

How green is your grass? A comparative analysis of the American and Canadian health care systems. Humane Med. 1991; 7(1):47-53. View in: PubMed

From the editors. Bioethics. 1990 Oct; 4(4):iii-. View in: PubMed

New attitudes needed on animal testing. New Sci. 1990 Aug 11; 127(1729):16. View in: PubMed

From the editors. Bioethics. 1990 Jul; 4(3):iii-. View in: PubMed

Bioethics and academic freedom. Bioethics. 1990 Jan; 4(1):33-44. View in: PubMed

From the editors. Bioethics. 1989 Oct; 3(4):iii-. View in: PubMed

Symposium: teaching and learning clinical medical ethics during residency training. Ann R Coll Physicians Surg Can. 1988 Sep; 21(6):423-6. View in: PubMed

Setting Limits: Medical Goals in an Aging Society, by Daniel Callahan. Bioethics. 1988 Apr; 2(2):151-69. View in: PubMed

Withdrawal from dialysis: an ethical perspective. Kidney Int. 1988; 34(1988):124-35. View in: PubMed

A report from Australia: which babies are too expensive to treat? Bioethics. A report from Australia: which babies are too expensive to treat? Bioethics. 1987 Jul; 1(3):275-83. View in: PubMed

Can bioethics be both rigorous and practical? Reseaux Ciephum. Can bioethics be both rigorous and practical? Reseaux Ciephum. 1987-1988; Nos. 53-54:121-9. View in: PubMed

The future of Baby Doe. New York Rev Books. 1984 Mar 1; 31(3):17-22. View in: PubMed

In vitro fertilisation: the major issues--a comment. J Med Ethics. 1983 Dec; 9(4):196-9. View in: PubMed

The blood feud: round two. Hastings Cent Rep. 1983 Aug; 13(4):48-50. View in: PubMed

Putting the problem on ice. Hum Life Rev. 1981; 7(4):104-8. View in: PubMed

Utility and the survival lottery. Philosophy. 1977 Apr; 52(200):218-22. View in: PubMed

Altruism and commerce: a defense of Titmuss against Arrow. Philos Public Aff. 1973; 2(3):312-20. View in: PubMed

Powered bySC CTSI